strated that the reduction of exercise tolerance in this patient population may be associated with skeletal muscle metabolic abnormalities manifested by early reliance on anaerobic metabolism.5-7 Forearm exercise in patients with heart failure was associated with increased phosphocreatine depletion, greater decrease in pH, and increased fatigability compared with normal subjects.5 '6 These changes occurred despite normal forearm blood flow, suggesting that skeletal muscle underperfusion was not the mediator of these abnormalities.5-7 These find-ings provoked speculation that intrinsic abnormalities of skeletal muscle develop in patients with chronic heart failure that impact substrate use and, subsequently, exercise tolerance.7
Several biochemical and histological abnormalities of skeletal muscle have been reported in patients with chronic heart failure. These include downregulation of p8-adrenergic receptors,8 endomysial fibrosis, increased lipid deposition and mitochondrial degeneration,9-'1 decreased capillary density,7 reduced proportion of type I myofibers,7 and development of fiber atrophy." There is no general agreement, however, that these abnormalities are indeed characteristic features of the skeletal muscle in chronic heart failure. A number of studies failed to show downregulation of 83-adrenergic receptors in skeletal muscle of patients with heart failure'2 or any changes in skeletal muscle fiber capillary density." Studies in dogs with heart failure produced by rapid ventricular pacing failed to show any changes in skeletal muscle fiber type composition.'3 These conflicting findings may be caused by factors related to the pathogenesis of heart failure, severity of hemodynamic compromise, extent of physical activity or lack thereof, nature of ongoing drug therapy in patients, and possibly to the specific skeletal muscle used for analysis. To minimize these confounding effects and at the same time address the question of intrinsic skeletal muscle abnormalities in chronic heart failure, we examined skeletal muscle characteristics in a well-described and standardized canine model of chronic heart failure produced by multiple sequential intracoronary microembolizations. Triceps muscle specimens were used to evaluate the potential existence of alterations in 1) , 8 -adrenergic receptor density, 2) proportion of type I and type II myofibers, 3) fiber size, 4) number of capillaries per fiber (C/F), and 5) myofibrillar and mitochondrial ultrastructural integrity. Methods The canine model of chronic heart failure used in the present study has been previously described and hemodynamically characterized in detail.14 In this preparation, chronic heart failure is produced by multiple sequential intracoronary embolizations with polysty- 
Data Analysis
A flow chart depicting the number of dogs used in the various components of the investigation is shown in Figure 1 . Comparisons between control dogs and heart failure dogs were based on a t statistic for two means. Among heart failure dogs, paired comparisons of hemodynamic and angiographic parameters between baseline and heart failure were based on Student's t test. In the seven heart failure dogs evaluated at three time intervals during the course of developing heart failure, temporal changes of LV 
Number of Capillaries per Fiber
In heart failure dogs, triceps muscle C/F (5.37±0.26) was not significantly different from control dogs (5.84±0.21) ( Table 2 ). There was no difference in any of the LV function parameters among dogs with heart failure in which C/F was evaluated compared with those in which it was not.
Triceps Muscle Ultrastructural Integrity
Qualitative examination of the ultrastructure of mitochondria-rich type I myofibers and glycogen-rich type II fibers in dogs with heart failure showed no abnormalities compared with control dogs. There was no evidence of myofibrillar or Z-band disruption and no evidence of excessive lipid content. Mitochondria were oval and contained electron-dense matrix and orderly tightly packed cristae. None of the mitochondria examined showed evidence of swelling, matrix clarification, or cristae disruption. Typical electron micrographs in a dog with heart failure are shown in Figures 2A and 2B .
Triceps Muscle Fiber Size
None of the skeletal muscle sections examined showed any evidence of focal regions of fibrosis. The cross-sectional areas of type I and type II fibers tended to be smaller in dogs with heart failure compared with control dogs (Table 2 ). This reduction in fiber size, however, was not statistically significant. The ratio of type I to type II average cross-sectional area was similar in heart failure dogs (0.94±0.12) compared with control dogs (0.88±0.03), indicating no preferential atrophy of either fiber type.
Triceps Muscle Fiber Type Distribution
The percentage of type I fibers was significantly lower in triceps muscle of heart failure dogs (19±2%) compared with control dogs (32±5%) (p<0.001), whereas the percentage of type II fibers was significantly increased in heart failure dogs (81±2%) compared with control dogs (68±5%) (p<0.001). The ratio of the number of type I to type II fibers was significantly lower in heart failure dogs than in control dogs ( (Table 3) .
Discussion
The present study demonstrates a decrease in the percentage of type I skeletal muscle myofibers and an increase in the percentage of type II myofibers in dogs with chronic heart failure resulting from loss of viable myocardium. Furthermore, these changes in skeletal muscle myofiber composition developed progressively during the course of evolving heart failure. The observed changes of skeletal muscle fiber types are not associated with preferential atrophy of either muscle fiber type and are not accompanied by changes in C/F, f3-adrenergic receptor density, or any identifiable myofiber ultrastructural abnormality.
The observed reduction in the percentage of slowtwitch type I fibers and the increase in the percentage of fast-twitch type II fibers in dogs with chronic heart failure are consistent with observations made in patients.7,26 Using biopsy specimens from the vastus lateralis muscle, Sullivan and associates7 showed a 31% reduction in the proportion of type I fibers and a 118% increase in type Ilb fibers in patients with chronic heart failure compared with normal subjects. Mancini et a126 used biopsies of the gastrocnemius muscle and showed a 13% reduction in the proportion of type I fibers and a 46% increase in the proportion of type II fibers in patients with chronic heart failure compared with normal subjects. In contrast with the present observations and those in patients, studies by Wilson and associates13 in skeletal muscle of dogs with experimental heart failure produced by rapid ventricular pacing failed to show any differences in the composition of skeletal muscle fiber types compared with control animals. This was true for the triceps, gracilis, and gastrocnemius muscles. In the present study, the gracilis and gastrocnemius muscles were not studied so as to avoid potential artifactual findings that may arise as a result of multiple catheterizations of the femoral arteries and veins.
We found no differences in the C/F, 83-adrenergic receptor density, or fiber ultrastructural integrity in skeletal muscle of dogs with heart failure compared with control animals. There was a tendency toward smaller type I and type II fibers in dogs with heart failure compared with control dogs and a significant reduction in fiber cross-sectional area of both type I and type II myofibers in dogs in which serial measurements were made. The ratio of type I to type II fiber cross-sectional area, however, was not different in any of the groups, indicating no preferential atrophy of either of the two fiber types. There is no general agreement with respect to skeletal muscle atrophy in patients with heart failure. Lipkin et all' reported atrophy of both type I and type II fibers of the quadriceps muscle of patients with heart failure. Caforio et a19 reported selective atrophy of type I fibers of both the right biceps brachii and the right deltoid muscle, whereas Mancini et a126 reported preferential selective atrophy of type II fibers of the gastrocnemius muscle. In contrast, Martin et a127 reported a nearly twofold increase in the cross-sectional area of both type I and type II fibers of the gastrocnemius muscle. The reasons for these wide-ranging differences of skeletal muscle fiber size are not clear. It is possible that variations are caused by differences in the pathogeneses of heart failure, the severity of the disease at the time of biopsy, and the extent of physical activity or the lack thereof. One possible explanation for moderate overall muscle fiber atrophy in the present study may be related to the extent of physical activity. Although every attempt was made to provide the dogs with sufficient space to allow for physical activity (large pens and exercise runs), it is possible that dogs may have become less active as heart failure ensued. It is interesting to note, however, that dogs that were trained to exercise on a treadmill manifested the same degree of fiber atrophy as dogs that were not successfully trained.
Other potential contributors to overall skeletal muscle atrophy include reduced caloric protein intake and chronic underperfusion of the skeletal muscle. ' tion may be tempered somewhat. Further studies are needed to elucidate the importance of these factors and others so as to ultimately identify the mechanisms responsible for exercise intolerance in heart failure.
In conclusion, the results of this study indicate that in skeletal muscle of dogs with chronic heart failure produced by multiple sequential intracoronary embolizations, there is a decrease in the relative composition of the highly oxidative, slow-twitch type I fibers and an increase in fast-twitch type II fibers. This shift in fiber type composition occurs progressively during the course of developing failure and does not appear to be associated with preferential atrophy of either of the two skeletal muscle fiber types or with a reduction of C/F, ,f-adrenergic receptor density, or fiber ultrastructural abnormalities.
